MLTX
Price
$53.09
Change
-$1.09 (-2.01%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
3.44B
20 days until earnings call
XENE
Price
$31.59
Change
-$0.53 (-1.65%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
2.42B
20 days until earnings call
Interact to see
Advertisement

MLTX vs XENE

Header iconMLTX vs XENE Comparison
Open Charts MLTX vs XENEBanner chart's image
MoonLake Immunotherapeutics
Price$53.09
Change-$1.09 (-2.01%)
Volume$3.34K
Capitalization3.44B
Xenon Pharmaceuticals
Price$31.59
Change-$0.53 (-1.65%)
Volume$17.51K
Capitalization2.42B
MLTX vs XENE Comparison Chart in %
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. XENE commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and XENE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (MLTX: $54.18 vs. XENE: $32.12)
Brand notoriety: MLTX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 106% vs. XENE: 48%
Market capitalization -- MLTX: $3.44B vs. XENE: $2.42B
MLTX [@Biotechnology] is valued at $3.44B. XENE’s [@Biotechnology] market capitalization is $2.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, XENE is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 4 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).

  • MLTX’s TA Score: 4 bullish, 4 bearish.
  • XENE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XENE is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а +10.84% price change this week, while XENE (@Biotechnology) price change was -2.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

XENE is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.44B) has a higher market cap than XENE($2.42B). MLTX YTD gains are higher at: 0.055 vs. XENE (-18.061). MLTX has higher annual earnings (EBITDA): -168.14M vs. XENE (-290.36M). XENE has more cash in the bank: 550M vs. MLTX (480M). XENE has less debt than MLTX: XENE (8.68M) vs MLTX (75.6M). XENE has higher revenues than MLTX: XENE (7.5M) vs MLTX (0).
MLTXXENEMLTX / XENE
Capitalization3.44B2.42B142%
EBITDA-168.14M-290.36M58%
Gain YTD0.055-18.061-0%
P/E RatioN/AN/A-
Revenue07.5M-
Total Cash480M550M87%
Total Debt75.6M8.68M871%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXXENE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
73%
Bearish Trend 11 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBPEX26.83N/A
N/A
Cantor Fitzgerald Equity Div Plus Inst
BRUDX16.49N/A
N/A
MFS Blended Research Value Equity A
JGTUX43.31N/A
N/A
JPMorgan Growth Advantage R4
TWGAX13.84N/A
N/A
American Century International Gr A
GITSX28.50N/A
N/A
Goldman Sachs Technology Opps Svc

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with IDYA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+3.16%
IDYA - MLTX
46%
Loosely correlated
-0.27%
XNCR - MLTX
46%
Loosely correlated
+2.72%
XENE - MLTX
44%
Loosely correlated
+1.58%
CLDX - MLTX
44%
Loosely correlated
-0.04%
CRNX - MLTX
44%
Loosely correlated
+3.51%
More